NCT01914432View on ClinicalTrials.gov

Efficacy and Safety Study of YH16410 Versus Rosuvastatin and Telmisartan Monotherapies in Patients With Hypertension and Hyperlipidemia

PHASE3CompletedINTERVENTIONAL

Enrollment

210

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions

HyperlipidemiaHypertension

Interventions

DRUG

YH16410

DRUG

Rosuvastatin

DRUG

Telmisartan

DRUG

YH16410 placebo

DRUG

Rosuvastatin placebo

DRUG

Telmisartan placebo

Trial Locations (1)

Unknown

Seoul National University Hospital, Seoul

All Listed Sponsors

lead

Yuhan Corporation

INDUSTRY

NCT01914432 - Efficacy and Safety Study of YH16410 Versus Rosuvastatin and Telmisartan Monotherapies in Patients With Hypertension and Hyperlipidemia | Biotech Hunter | Biotech Hunter